Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality von Tamaki, Nobuharu, Kimura, Takefumi, Wakabayashi, Shun‐Ichi, Umemura, Takeji, Kurosaki, Masayuki, Loomba, Rohit, Izumi, Namiki

Volltext

Editorial: Has MetALD met the presumption? Authors' reply von Tamaki, Nobuharu, Kimura, Takefumi, Wakabayashi, Shun‐Ichi, Umemura, Takeji, Izumi, Namiki, Loomba, Rohit, Kurosaki, Masayuki

Volltext

Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients von Okumura, Taiki, Joshita, Satoru, Iwadare, Takanobu, Wakabayashi, Shun‐ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Kimura, Takefumi, Umemura, Takeji

Volltext

Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease von Tamaki, Nobuharu, Wakabayashi, Shun‐Ichi, Kimura, Takefumi, Yasui, Yutaka, Tsuchiya, Kaoru, Nakanishi, Hiroyuki, Huang, Daniel Q., Umemura, Takeji, Kurosaki, Masayuki, Izumi, Namiki

Volltext

Acute liver failure with severe steatosis induced by mushroom von Wakabayashi, Shun‐ichi, Kimura, Takefumi, Tanaka, Naoki

Volltext

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease von Tamaki, Nobuharu, Kimura, Takefumi, Wakabayashi, Shun‐Ichi, Umemura, Takeji, Izumi, Namiki, Loomba, Rohit, Kurosaki, Masayuki

Volltext

Letter: Filling the Gaps—Enhancing MASLD Prognosis With Imaging, Diverse Populations and Extended Follow‐Up. Authors' Reply von Tamaki, Nobuharu, Kimura, Takefumi, Wakabayashi, Shun‐Ichi, Umemura, Takeji, Izumi, Namiki, Loomba, Rohit, Kurosaki, Masayuki

Volltext

Editorial: Cardiometabolic criteria matters in MASLD—Authors' reply von Tamaki, Nobuharu, Kimura, Takefumi, Wakabayashi, Shun‐Ichi, Umemura, Takeji, Izumi, Namiki, Loomba, Rohit, Kurosaki, Masayuki

Volltext

Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease von Kimura, Takefumi, Iwadare, Takanobu, Wakabayashi, Shun‐ichi, Kuldeep, Seema, Nakajima, Tomoyuki, Yamazaki, Tomoo, Aomura, Daiki, Zafar, Hamim, Iwaya, Mai, Joshita, Satoru, Uehara, Takeshi, Pydi, Sai P., Tanaka, Naoki, Umemura, Takeji

Volltext

2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease von Fujimori, Naoyuki, Kimura, Takefumi, Tanaka, Naoki, Yamazaki, Tomoo, Okumura, Taiki, Kobayashi, Hiroyuki, Wakabayashi, Shun‐ichi, Yamashita, Yuki, Sugiura, Ayumi, Pham, Jonathan, Pydi, Sai P., Sano, Kenji, Joshita, Satoru, Umemura, Takeji

Volltext

aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C von Yamashita, Yuki, Joshita, Satoru, Sugiura, Ayumi, Yamazaki, Tomoo, Kobayashi, Hiroyuki, Wakabayashi, Shun‐ichi, Yamada, Yosuke, Shibata, Soichiro, Kunimoto, Hideo, Iwadare, Takanobu, Matsumura, Makiko, Miyabayashi, Chiharu, Okumura, Taiki, Ozawa, Sachie, Nozawa, Yuichi, Kobayashi, Natsuko, Komatsu, Michiharu, Fujimori, Naoyuki, Saito, Hiromi, Umemura, Takeji

Volltext

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients von Joshita, Satoru, Ota, Masao, Kobayashi, Hiroyuki, Wakabayashi, Shun-ichi, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Tanaka, Eiji, Umemura, Takeji

Volltext

Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients von Iwadare, Takanobu, Kimura, Takefumi, Tanaka, Naoki, Yamazaki, Tomoo, Wakabayashi, Shun-ichi, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Pydi, Sai P., Nakajima, Tomoyuki, Iwaya, Mai, Sugiura, Ayumi, Joshita, Satoru, Uehara, Takeshi, Umemura, Takeji

Volltext

Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project von Kobayashi, Hiroyuki, Joshita, Satoru, Akahane, Yuki, Matsuzaki, Katsuhiko, Yamada, Hiromi, Aomura, Daiki, Joshita, Nao, Midorikawa, Hajime, Suyama, Kazuhiro, Ota, Masao, Wakabayashi, Shun-Ichi, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Misawa, Hiromichi, Umemura, Takeji

Volltext

Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease von Wakabayashi, Shun-Ichi, Joshita, Satoru, Kimura, Kazuhiro, Motoki, Hirohiko, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Kuwahara, Koichiro, Umemura, Takeji

Volltext

Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients von Umemura, Takeji, Joshita, Satoru, Saito, Hiromi, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Ota, Masao

Volltext

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease von Wakabayashi, Shun‐Ichi, Joshita, Satoru, Kimura, Kazuhiro, Motoki, Hirohiko, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Kimura, Takefumi, Kuwahara, Koichiro, Umemura, Takeji

Volltext

Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myelo... von Yamazaki, Tomoo, Joshita, Satoru, Ichijo, Tetsuya, Kobayashi, Hiroyuki, Wakabayashi, Shun-ichi, Yamashita, Yuki, Sugiura, Ayumi, Kawakami, Fumihiro, Nakazawa, Hideyuki, Umemura, Takeji

Volltext

Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literat... von Yamashita, Yuki, Joshita, Satoru, Kobayashi, Hiroyuki, Wakabayashi, Shun-Ichi, Sugiura, Ayumi, Yamazaki, Tomoo, Umemura, Takeji

Volltext

Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease von Wakabayashi, Shun-Ichi, Tamaki, Nobuharu, Kimura, Takefumi, Umemura, Takeji, Kurosaki, Masayuki, Izumi, Namiki

Volltext